Erythrocyte aggregation and -455G/A polymorphism of the β-fibrinogen gene in survivors of acute myocardial infarction [6]

Thrombosis and Haemostasis

Volumn 92, Issue 1, 2004, Pages 223-224

  Vayá, Amparo ^a   Breña, Silvia ^a   Réganon, Edelmiro ^a   Virtudes, Vila ^a   Martínez Sales, Vicenta ^a   Contreras, Maria Teresa ^a   Zorio, Esther ^a   Corella, Dolores ^b   Aznar, Justo ^a  

^a HOSPITAL UNIVERSITARIO LA FE   (Spain)

^b UNIVERSITY OF VALENCIA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; DNA; FIBRINOGEN; GLYCINE; LIPID; TRIACYLGLYCEROL;

ACUTE HEART INFARCTION; ALLELE; BLOOD SAMPLING; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DNA ISOLATION; DNA POLYMORPHISM; ERYTHROCYTE AGGREGATION; FIBRINOGEN BLOOD LEVEL; GENE MUTATION; GENETIC ASSOCIATION; GENOTYPE; HUMAN; LETTER; MAJOR CLINICAL STUDY; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN STRUCTURE; STATISTICAL ANALYSIS; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 3543007730     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1613649     Document Type: Letter

References (14)

1. Demiroglu H. The importance of erythrocyte aggregation in blood rheology: Considerations on the pathophysiology of thrombotic disorders. Blood 1997; 89: 4236.
2. Chien S, Jan KM. Red cell aggregation by macromolecules: roles of surface adsorption and electrostatic repulsion. J Sup Structure 1973; 1: 385-409.
3. Nash GB, Wenby RB, Sowemimo-Coker SO, et al. Influence of cellular properties on red blood cell aggregation. Clin Hemorheol 1987; 7: 93-108.
4. Weng X, Cloutier G, Genest J Jr. Contribution of the -455G/A polymorphism at the β-fibrinogen gene to erythrocyte aggregation in patients with coronary artery disease. Thromb Haemost 1999; 82: 1406-11.
5. Vayá A, Falcó C, Réganon E, et al. Influence of plasma and erythrocyte factors on red blood cell aggregation in survivors of acute myocardial infarction. Thromb Haemost 2004; 91: 354-59.
6. Thomas AE, Green FR, Kelleher CH, et al. Variation in the promoter region of b-fibrinogen levels in smokers and no-smokers. Thromb Haemost 1991; 65: 487-90.
7. Heinrich J, Funke H, Rust S, et al. Impact of polymorphisms in the alpha- and beta-fibrinogen gene on plasma fibrinogen concentrations of coronary heart disease patients. Thromb Res 1999; 77: 209-15.
8. Scarabin PY, Bara L, Ricard S, et al. Genetic variation at the β-fibrinogen focus in relation to plasma fibrinogen concentrations and risk of myocardial infarction. The ECTIM study. Arterioscler Thromb 1993; 3: 886-91.
9. Behague I, Poirier O, Nicaud V, et al. β-fibrinogen gene polymorphisms are associated with plasma fibrinogen and coronary artery disease in patients with myocardial infarction. The ECTIM study. Circulation 1996; 93: 440-9.
10. Leander K, Wiman B, Hallqvist J, et al. The G-455A polymorphism of the fibrinogen Bβ-gene relates to plasma fibrinogen in male cases, but does not interact with environmental factors in causing myocardial infarction in either men or women. J Int Med 2002; 252: 332-41.
11. Green F, Hamsten A, Blombäck M, et al. The role of β-fibrinogen genotype in determining plasma fibrinogen levels in young survivors of myocardial infarction and healthy controls from Sweden. Thromb Haemost 1993; 70: 915-20.
12. Carter AM, Stickland MH, Mansfield MW, et al. β-fibrinogen gene -455 G/A polymorphism and fibrinogen levels: Risk factors for coronary artery disease in subjects with NIDDM. Diabetes Care 1996; 19: 1265-8.
13. Wang XL, Wang J, McCredie RM, et al. Polymorphisms of factor V, factor VII and fibrinogen genes: Relevance to severity of coronary artery disease. Arterioscl Thromb Vasc Biol 1997; 17: 246-51.
14. Maghzal GJ, Brennan SO, George PM, Fibrinogen Bβ polymorphisms do not directly contribute to an altered in vitro clot structure in humans. Thromb Haemost 2003; 90: 1021-8.